SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001571049-14-004086
Filing Date
2014-08-15
Accepted
2014-08-15 16:41:24
Documents
1
Period of Report
2014-08-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT t1401601_peterson-f4.html 4  
1 OWNERSHIP DOCUMENT t1401601_peterson-f4.xml 4 4036
  Complete submission text file 0001571049-14-004086.txt   5632
Mailing Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS BLDG., SUITE 290 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS BLDG., SUITE 290 RESEARCH TRIANGLE PARK NC 27709 (609) 986-1780
NephroGenex, Inc. (Issuer) CIK: 0001338095 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEPHROGENEX, INC. 79 T.W. ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address
Peterson Bob (Reporting) CIK: 0001597014 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36303 | Film No.: 141046995